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FEST is a Norwegian database and information service aimed towards providing all the 
required pharmaceutical data to different stakeholders such as hospitals, pharmaceutical 
companies, and practitioners. FEST being a complete pharmaceutical database, ensures every 
information related to drugs such as dosage, form of drug, interactions, and brand. FEST 
database is represented as an XML and schema files. In this master thesis, we propose an open 
and linked data representation approach of FEST database by modelling it as an Ontology. We 
propose the integration of FEST ontology with other systems and ontologies for semantic 
interoperability which is one of the main challenge in current e-health world. We propose in 
this thesis a method for the representation of drug-drug interaction in context with patient’s 
family member history. We will use SPARQL queries on existing data in FEST ontology to 
generate implicit information about possible drug-drug interaction. Using the existing drug 
interactions in FEST, we will represent a method to classify those interactions according to 
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The current modern world is finding IT solutions for common problems in every field of life, 
and domain of e-health is no exception. System developers are making tools to provide better 
healthcare systems for different domains such as hospitals, pharmacies, and patients. When it 
comes to pharmaceuticals, we find many different systems such as SystemX1, Kjernejournal2, 
and DINTO3, that are being utilized to represent varied information related to patient journals 
and drugs such as interactions, dosage, and side effects. FEST is also such a system, used in 
Norway, that exposes pharmaceutical information to pharmacies, labs, patients, practitioners, 
and hospitals. HL7 is also working towards defining standard protocols for clinical information 
exchange between different systems. Representation of FEST as an ontology will help us not 
only to infer more data from the existing, but also to integrate FEST with other health care 
systems and ontologies such as DINTO, SNOMED and FHIR.  
1.1 Background 
Artificial intelligence, automatic decision-making capabilities, and representation of big data 
is of huge interest [1]for current research community. More and more efforts are being made 
to make the computers able to make decisions according to defined standards and rules. This 
results in more meaningful and usable interpretation of stored data. In the e-health world, we 
see different intelligent systems and technologies such are developed to aid practitioners and 
health industry. That includes, but is not limited to, databases to store pharmaceutical 
information, EHR’s of patients etc.  
Semantic web also enables the machines and computers to read the stored data and extract 
valuable information. Let’s take an example from real world, If we want to retrieve a list 
containing  heads of department of different universities, it may not be possible to do it by 
simply searching through a search engine. The information is available on the internet, but still 
is not accessible in form of  a list. This is due to the fact that information is stored in such a 
format that machines are unable to make a meaning of that data. Suppose If the information is 
stored in such a manner that computers can read it and interpret its meaning according to 
defined rules. In this case, we do not need to go through multiple webpages to retrieve the 






concerned list . Figure below illustrates the example of storing information in machine readable 
format: 
 
Figure 1.1 Representation of heads of department 
Every head of department will be stored with an property hasHOD, and we then simply has to 
query for all the objects that are linked with this property, which will generate us a list. 
This thesis will contribute to the field of e-health and semantic interoperability by utilizing the 
logics of semantic web. We bring forward a representation of FEST database as an ontology to 
enable reasoning and inferencing, and to integrate the FEST ontology with other ontologies to 
provide better solutions for problems such as generating information for drug interactions. 
1.2 Motivation 
Motivation behind this particular master thesis is mainly to contribute to the health industry of 
Norway by encouraging use of ontologies for clinical data exchange, and to aid to semantic 
interoperability. The Norwegian Medicines Agency is also working on a similar concept to 
enable representation of FEST as open and linked data [2], and a short communication with 
one of the adviosrs working there also gave us positive feedback about working with the FEST 
model. We have been working in the fielkd of e-Health from the last two years,and have done 
three different projects which has motivated us to continue working in this direction because 
we believe there are several possibilities in this field to explore. 
1.3 Problem Statement and Goals 
Exposure of pharmaceutical data to different stakeholders such as hospitals, pharmaceutical 
companies, doctors etc. in Norway is currently done by using FEST database. All the 
stakeholders have to download the XML files, which are regularly updated, and put them in 
their systems, or they have to use an automatic system that searches periodically for the updates 
and downloads the new version by itself. We demonstrate and establish in this thesis that an 
ontological representation of FEST can lead to many advantages such as semantic 
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interoperability, and integration with other ontologies. We also expect to exhibit some of the 
use cases by inferring new information from the existing data. FEST administration is also 
working on representing the data using an ontology, and so far they have represented 1-2 
resources for messaging. This thesis, however, will particularly address the following issues: 
• Developing an ontological model of FEST database for the representation of 
pharmaceutical data  
 Ontology should at least represent all the information related to drugs, i.e. 
coding system, ingredients/substances etc. 
• Using the ontological model to represent implicit drug-drug interaction in context 
to patient’s family member history. 
• Using the FEST ontological model to represent drug interaction mechanisms. 
 
1.4 Key suppositions and Limitations 
We have made certain constraints and suppositions when it comes to ontological representation 
of FEST. The ontology mainly focuses on drug related information, and doesn’t necessarily 
deals with the information related to the catalogues such as Refusjon, Vilkår, Byttegruppe, 
and Handelsvare. We also have certain limitations on drug-drug interaction representation 
also. For example, currently we only represent drug interaction between only two 
drugs/substances. Moreover, this thesis does not focus on description and in-depth working of 
FEST XML database. However, we have described the purpose and usage of classes that we 
have mapped to the ontology in relevant chapter. The classes and attributes in ontology are 
developed in Norwegian language, because we believe that continuation of this thesis would 
be to import the data instances from FEST XML, and same language vocabulary will be 
beneficial. However, for the purpose of understanding, we have added a description of 
Norwegian words in APPENDIX A. 
1.5 Related work  
As discussed previously, two of the catalogues that are VarselfraSLV, and Kodeverk have 
been represented using an ontology [3] by Norwegian Medicines Agency. At the moment, 
notifications are sent to pharmacies and hospitals  in form of simple text. Kodeverk and 
Pakning catalogues are not completely implemented, and the only information from these 
catalogues which is linked with VarselfraSLV is represented as an ontology. The catalogue 
VarselfraSLV, implemented as an ontology is used to send notifications about certain issues 
such as warnings, drug shortage and safety messages. While catalogue Kodeverk is used to 
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store information related to different coding systems used in FEST. Please refer to section 3.13 
and 3.14 for more information about these catalogues. 
In the field of semantic web, a sub group of HL7 ITS work group, known as RDF group is also 
working on different projects to encourage use of RDF for exchanging healthcare information. 
One of their project is to represent FHIR resources in RDF format [4].   
When it comes to drug-drug interactions, DINTO and DIO are two well-known ontologies used 
for classification of drug interactions. We also submitted a paper “Mapping FHIR Resources 
to Ontology for DDI reasoning” in SHI 2017: Scandinavian Conference on Health Informatics 
and are yet to receive comments. In this paper, along with co-authors, we developed an 







 Literature Review 
2.1 Theoretical Background 
2.1.1 Semantic Web 
Semantic web, an approach which differs to the traditional web, is generally termed and 
described as a “Web of data”. A Web of data may consist of dates, properties, numbers, names, 
and in general any data that we can imagine and think of. As further described by W3C, 
fundamental moto of the semantic web is to make the data machine readable, because mostly 
in the web techniques like HTML, data is only for human consumption. While in semantic 
web, machines can read the data, deduce meaning from that, and link it with other information 
through inference to provide more meaningful, and in some cases implicit, information. 
Technologies (RDF, SPARQL, OWL, SWRL etc.) that are defined under the umbrella of 
semantic web, enable us to build databases, vocabularies, and rule bases to manipulate the 
stored information [5]. 
Benefit of semantic web is realized through Linked and Open data. We have huge amount of 
data currently available over the internet, and is stored using different schemes and databases. 
Rules and relations can be defined in a proper and standardized way to link this data and make 
it available across multiple applications and systems. 
Vocabularies or terms are one of the most fundamental part of semantic web and linked data. 
Imagine, for instance, the vocabulary used in medical industry to describe different information 
related to drugs, diseases, symptoms and prescriptions [6]. A common and standardized 
vocabulary, in this case, to represent drug information can enable different institutions, 
pharmacies, and researchers to exchange data between different platforms, which will enable 
to create more sophisticated decision support systems for better and enhanced treatment. 
Another aspect of semantic web is the powerful query language support. Technologies such as 
SPARQL, Description Logic, and SWRL Rules are widely used to query and infer data. In 
some sense, similar to querying relational databases, SPARQL queries are used to retrieve and 
store data in semantic web.  
Inference in the semantic web terminology is effectively used to deduce more information from 
the already existing data by defining specific rules and restrictions. Inference on semantic data 
enables to generate implicit data, which means that we don’t have to define explicitly all the 
data related to a particular entity. For example, if we have a database of a family, we don’t have 
to define all the relations between every individual. Let’s say if X has father Y, and Y has father 
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Z, then it’s not required to explicitly state that X is grandchild of Z. Instead, we can create a 
rule base with specific rules about who can be classified as a grandchild, and then through 
inference we can generate this implicit relation.  
Tim Berners-Lee , known as father of world wide web, explains the concept of semantic web 
in an informal way by stating that “The Semantic Web is an extension of the current web in 
which information is given well-defined meaning, better enabling computers and people to 
work in cooperation." [7]. A visual representation of the structure realized by Tim Berners-Lee 
is shown in the figure below which is often termed as Semantic web tower: 
 
 
Figure 2.1 Layers of Semantic web tower [7] 
The layers in the tower are used to represent concepts at different levels with Unicode and 
URI’s at the lowest level. When we move upwards in the tower, the concepts get more 
knowledgeable such as Ontology, RDF Schema, and logics. Concepts at higher levels have 
more detailed description of information.  
2.1.2 Ontology 
An ontology, as defined by Webster, is a study of metaphysics and explains philosophically 
the nature of being, and entities that are abstract. [8] An ontology explains the metaphor of 




Figure 2.2 Tree of Porphyry [9] 
A logician from 13th century, known as Peter of Spain, explained and classified different 
entities according to their features and properties [9]. Different entities were placed under 
different categories with all of them having a common supreme category Substance. We realize 
from the Tree of Porphyry that as we move down the structure, the entities get more concrete 
meaning as opposed to the top level which defines abstract concepts. This same concept is used 
in the world of computer science today. Classes, in computer science terminology, describe a 
group of different things having same features, characteristics, and activities. To further 
describe this concept, take an example of the category Animal in the Tree of Porphyry. In 
computer world, Animal would be defined as a class, which further has sub classes of Human 
and Beast differentiated respectively through a quality of being rational and irrational. Humans 
have further definition known as individuals like Plato, Socrates etc. All of these individuals 
have some similar features and are thus defined under the class Human. These individuals are 
defined as Objects or Instances in the world of computer science. 
In the field of data representation, ontologies can significantly minimize the complexity of 
information and arrange the data in a meaningful way. Ontologies can be designed in different 
standardized formats such as OWL, RDF, and Turtle as shown in the figure 2.2. It is very 
popular and practicable to build and model data information using ontologies in different 
sectors such as e-Health, education, agriculture, transportation etc. For example, DINTO is an 
ontology used to systematically capture drug-drug interaction and related information. DINTO 
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is not only used to represent the interactions, but also describes different mechanisms that can 
lead to these drug interactions [10]. We have also used the similar concept of representing DDI 
mechanisms in this thesis by extending the FEST ontology.  
SNOMED CT is also one of the most sophisticated ontology in the medical filed, and is used 
to represent standardized clinical terminologies. At current, SNOMED CT is used by more than 
20 different projects overall the world [11], and one of them include an ongoing project at 
Norwegian Institute of Public Health, which is the mapping of Norwegian national quality 
registries. Their goal is to systematically map all the existing overlapping variables under 
national registers such as Medisinsk fødselsregister4, Reseptregisteret5, and  Nasjonalt 
vaksinasjonsregister6. The mapping of such all resources such as archetypes, templates, and 
other vocabularies is included in the project [12] . The figure below shows and example of 
classes and properties defined in SNOMED CT ontology. 
 
Figure 2.3 Example of SNOMED CT 
 
Use of ontologies in some domains have always been more popular than the others. In a survey 
published by Jorge Cardoso in IEEE Intelligent Systems in 2007, showed that most popular 
domain to utilize the ontologies was Education and computer science while the usage of 






ontologies among health industry was not much popular as compared with Education [13]. The 
figure below shows they survey result: 
 
Figure 2.4 Ontologies in different domains 2007 [13] 
This trend was shown to be changing by the survey done in 2013 by Sai Baba Magapu [14]. In 
the journal published in International Journal of Applied Information Systems, he argues that 
Medical field was one of the most promising field to utilize the ontologies. This shows that 
there is a great trend in the health sector to represent clinical data using ontologies. Ontologies 
define concepts and their relations to form a complete model. Most of the ontologies created 
in current computer world have following core components [15]: 
CLASS: core concept, represents individuals having same features. For example, Human is a 
class to represent all the humans, Man and Woman are subclasses of Human having more 
specific details. 
OBJECT: instances that are described by the concepts defined in Classes. For example, Ole is 
an object of class Man, thus it possesses all the features of a Man. 
PROPERTIES: relations used to connect individuals with other individuals and classes.  
Figure 2.5 below shows an example of class structure from our paper “Mapping FHIR 
resources to ontology for DDI reasoning” that has been submitted to Scandinavian Conference 




Figure 2.5 Class structure of FHIR ontology 
Every class may have further subclasses or individuals. For example, the class Medication 
represent individuals of particular drugs along with their details.   
2.1.3 Resource Description Framework 
In the semantic world, RDF is a framework to represent data information using triples. W3C 
describes the structure of RDF as set or triples having subject, object and a predicate [16]. Each 
set of triples is known as RDF Graph which is visually represented in the figure below: 
 
Figure 2.6 A typical RDF graph [16] 
Subject in the figure above is used to describe a thing, while Object is a thing on which an 
action is being performed. Predicate, as visible, is used to define the relation between subject 
and a particular object. For example, a triple “Ole loves Jenny”, has subject “Ole” and object 
“Jenny”, while predicate “loves” is used to describe the relation of love between these two 
objects. Below is an example of an RDF triple from our paper: 
 
Figure 2.7 Example from FHIR Ontology 
The figure above shows that an example of RDF triple with class Medication having two 
individuals namely Moclobemide and Efavirenz. Two triples are generated that are “Efavirenz 
19 
 
rdf:type Medication” and “Moclobemide rdf:type Medication ”. Medication is a subject 
while Efavirenz and Moclobemide are two objects. 
RDF Schema, commonly known as RDFS, is an extension of RDF to provide data-modelling 
vocabulary [17]. As described by W3C, RDFS is complimented by different RDF concepts, 
RDF semantics, and standardized syntaxes such as JSON-LD and TURTLE [17]. Basic 
components of an ontology (Class, Object, Property) that we discussed earlier, are defined 
using RDFS. In case of properties, the domain and range is also defined using RDFS. It is 
argued that RDFS class, object and property have certain similarities with object oriented 
concepts. The namespace for RDFS definitions is defined by W3C and is published as IRI 
www.w3.org/2000/01/rdf-schema#. 
2.1.4 Extensive Markup Language 
XML is a markup language based on SGML7 developed in 1996, and is used to represent 
structured data and information. This data can belong to any domain such as data from libraries, 
pharmacies, receipts,  etc. XML documents are well defined according to certain rules, and 
users can create custom tags to give a more logical and meaningful order to the information. 
One may also say, due to capability of user tags, XML is quiet similar in some aspects with 
HTML [18]. But when we say XML have similar concepts, it doesn’t mean that their purpose 
of usage is same. HTML was designed predominantly to aid the display of information and 
data on world wide web, while XML documents are predominantly used for the sharing of data 
and information between systems running on different machines. Because the data being 
represented using XML documents has to be well formed, in order to make it machine-
readable, implies that any XML document with syntax errors, logical errors will not get 
compiled without the particular errors being fixed [18]. An example XML code snippet is 
shown in the figure below which is taken from our paper: 





Figure 2.8 Example of XML code 
Figure 2.8 shows a code used to associate a drug by using two different coding schemes, ATC 
and SNOMED CT. All the tags shown in the figure i.e. code, coding etc. are not pre-defined 
tags, and are created by the user to give meaning to the stored data. FEST database, which is 
established by Norwegian Medicines Agency, is also published and delivered in XML format.  
2.1.5 SPARQL 
We have discussed how RDF is used to build structured database and store information which 
is readable by machines and computers. One of the most eminent task how efficiently and 
robustly that data can be retrieved. SPARQL , being a query language to retrieve RDF data, 
has proven to be of great help in this regard. SPARQL query language consists of different 
protocols and standard rules to retrieve RDF data, and these set of protocols are maintained 
and updated by W3C [19].  
SPARQL query is also based on concept of triples, i.e. subject, predicate, and object. Similar 
to RDF, every entity (subject, object, predicate) is identified using IRI’s. For example, we 
discussed the namespace of the IRI for RDFS, and whenever we have to access any class 
defined with RDFS namespace, we simply use prefixes rdfs in combination with colon “:” and 
property name to access the IRI. Prefixes for a specific IRI can also be defined by the user 
itself. An example of  RDF graph along with SPARQL query is shown below which is taken 




Figure 2.9 Example of a SPARQL query 
The query above is used to determine whether there is an interaction between two drugs namely 
Aspirin, and Edoxaban. For the property and objects, a default blank prefix is used to identify 
the resource. Value of “x” depends whether both the triples are true or not. Figure below shows 
result generated in an web application for the query above, which is also taken from our 
previous project: 
 
Figure 2.10 Query result for drug interaction 
The result returned by the query is “ASPIRIN_EDOXABAN_DDI” which classifies that there 
is an interaction between these two drugs, implying that both the triples in the query were found 
to be true. SPARQL queries are not only used to retrieve data, but they can also be used to 
manipulate the stored data and add new information (triples) into the RDF store. We can also 
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use certain queries to define some rules, and then generate inferred data by implying those rules 
on the existing data. CONSTRUCT [19]  query is used to generate such implicit data based on 
user defined rules. ASK [19] queries can be used to simply establish whether a particular triple 
(which may be a fact, date, name etc.) exists or not. 
2.1.6 Semantic Interoperability 
Semantic Interoperability, being one of the strong motivation behind this master thesis, needs 
an unambiguous, comprehensible, and explicit interpretation. Interoperability, in general, as 
defined by oxford dictionary is “the ability of computer systems or software to exchange and 
make use of information” [20]. In terms of computer science, Semantic interoperability can be 
further explained as the capability of two or more different systems, running independently on 
different or same networks, to communicate and share data information with each other so that 
the researchers or stakeholders can take full advantage of every bit of information available on 
those systems.  
Semantic interoperability doesn’t only deal with the sharing of data, but also concerns about 
how the semantic meaning of the information can be shared, and how can metadata and 
vocabulary can be extended so that the receiving systems can interpret and infer more data 
[21]. To conceptualize the significance of semantic interoperability, we can consider an 
example of two healthcare systems using same protocols to exchange clinical information. If a 
patient moves from one healthcare systems to another, then his patient journal from previous 
system should be exchanged in such a way that new system can interpret the incoming data 
and integrate it with current system. In this way, the patient can get better health care service 
which shows one of the potential benefit of semantic interoperability.  
Achieving semantic interoperability is not as simple task as it seems, because every domain 
needs standardization of multiple factors to truly enable information exchange across systems. 
Heath care industry has been encouraging the utilization of interoperability systems to enable 
better patient care services. In this regard, RDF was proposed to be top of the line language 
protocol for the exchange of healthcare and clinical data across systems [22]. This development 
came when President's Council of Advisors on Science and Technology (PCAST) invited to 
submit proposals for a universal language for healthcare data exchange. It was called as 
Yosemite Manifesto, and is signed by more than 100 researchers and representatives of 
different organizations who are currently working in the field of healthcare information 




Figure 2.11 Yosemite's interoperability roadmap [22] 
The roadmap to enable semantic interoperability for healthcare systems has a fundamental 
approach to use RDF for the information exchange. As showed in the figure above, and 
explained by Yosemite’s manifesto, clinical or general healthcare information must be 
exchanged in typical RDF format, or mapping should be done to translate the existing 
information in RDF format. We can avoid developing new standards for all the existing data 
models, and define only certain standards which will enable us to connect the existing data 
models with each other. It is also asserted that, in addition to mapping the existing vocabularies 
and information to RDF format, new standards and data models should also be presented in 
RDF format. This semantic interoperability should also be incentivized by governments, health 
agencies, and corporations. This is to encourage interoperability and counter the business 
competition hurdles between organizations [22]. However, the claim about RDF, despite of 
being signed by more than 100 bodies,  is not well received by all the researchers. Thomas 
Beale, a senior architect at openEHR, argues against the use of RDF as a universal and only 
language for clinical information exchange. He concludes and establishes that we should define 
certain domains and problems where RDF is applicable and beneficial, and where it is 
inapplicable [23].  
One of the most promising project, in the health care systems, is the ongoing work by HL7 ITS 
work group for RDF representation of FHIR resources [4]. We also demonstrated a use case in 
our paper of drug interactions by customizing the unofficial draft ontology of FHIR and 
extracting clinical data from FHIR servers. The figure below shows an example of using RDF 




Figure 2.12 RDF graph for FHIR and HL7v2 [10] 
The message in HL7 v2.x represents the same information that is represented using the FHIR 
resources in XML format on the right side. Despite being different formats, by doing precise 
mapping, the information can be represented by a single RDF graph. To argue more about the 
advantages, we can define some inference rules to generate new inferred data from the RDF 
graph represented in the figure above, and which was also successfully demonstrated in our 
paper. 
2.1.7 Norwegian Electronic Prescription Support System (FEST) 
FEST is a database, which includes all the information about drugs that are being prescribed in 
Norway, and is provided as an information system service by Norwegian Medicines Agency 
to almost all the hospitals, pharmacies, and drug producers. A physician, general practitioner, 
or a researcher can get all the possible information of a particular drug which can be prescribed 
in Norway through FEST database. Motivation behind the development of FEST database, as 
described by Norwegian Medicines Agency, was to encourage and support safe medication and 
prescription in Norway. FEST makes it possible to endorse safe medication because different 
stakeholders such as hospitals, pharmacies etc. will be getting all the drug related information 
from a single source which minimizes the risks of unsafe prescription [24]. Norwegian 
Medicines Agency encourages the usage of single source for pharmaceutical entities by 
following arguments: 
 Centralized information and regular update enables efficient resource utilization. 
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 Because the data will be coming from one source (FEST), it will enable standardization 
and regulation throughout the health industry. It will also enable to generate useful 
statistics about the usage of certain drugs. 
 Communication and collaboration between hospitals, pharmacies, drug manufacturers, 
and researchers can be more productive. 
 End user such as patients will get more benefit through this system as prescriptions will 
get better and safe through experience and regular updates  [24].   
 FEST can also be used by researches, working in the field of drug and patient safety, to 
develop more effective patient safety models by combining it with other systems. 
 FEST can also lead towards semantic interoperability, which is also demonstrated in 
this thesis. 
FEST database is mainly developed in XML format, and regular updates are made to it. 
Because it is developed in XML format, it require systems to use certain applications which 
can read that XML database and provide user interface according to the stakeholder. FEST is 
currently used by different stakeholders which are presented in the figure below: 
 
Figure 2.13 FEST usage by different Stakeholders [25] 
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Figure 2.13 shows how FEST is used in different services such as patient journals, prescription, 
and drug interaction services i.e. www.interaksjoner.no. The figure also shows it’s usage by 
different stakeholders such as hospitals, pharmacies and Norwegian Health Economics 
Administration (HELFO).  
Doctor and practitioners use FEST while prescribing a medicine, and to check for different 
aspects of that particular medicine such as side effects, interactions, price etc. They can choose 
alternatives to a particular drug if it can incur hazardous side effects to certain patients. 
Hospitals and pharmacies can use FEST to keep track of medicines and equipment. They can 
send messages to responsible stakeholder in case of emergency such as informing about 
unregistered side effects of certain medicines or informing about shortage of certain drugs. 
Norwegian Medicines Agency doesn’t alone have the complete information and database 
related to different drugs, but they collaborate with different state agencies such as Norwegian 
Directorate of Health, HELFO, and Norwegian Pharmacy Association [26]. Despite the fact 
that data in FEST itself comes from different organizations, it is still regulated and modelled 
according to FEST standards to maintain coherence between different systems. 





Figure 2.14 FEST overview [25] 
For explanation of Norwegian vocabulary used, please refer to Appendix A. The catalogues in 
blue are generally used for the prescription of a medicine, substance, and to determine whether 
a particular medicine can be given freely on blue receipt. M30 FEST includes all the catalogues 
used to describe drug related information, rules for prescription, warnings, dosage information 
etc. It is important to mention that M30 catalogues are not disjoint with other catalogues and 
may also depend upon some of the catalogues from Prescription (Forskrivning), and division 
shown in the figure merely represents the catalogues which are required for different use cases. 
A detailed information of catalogues is presented in chapter 3, along with their mapping to the 
ontology.  
2.1.8 ATC Classification System (ATC) 
ATC classification system, as described by WHOCC, is a widely used drug classification 
system which is combined with Defined Daily Dosage (DDD) system to provide drug 
utilization research possibilities across the world. ATC system was an extension and adapted 
version of  Anatomical Classification system (AC-system), developed by Norwegian 
researchers. Further collaboration with Nordic Council on Medicines (NLN), and then with 
World Health Organization (WHO) resulted in a very sophisticated ATC/DDD system, and is 
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currently used effectively to measure and generate statistics about the consumption of drugs 
[27]. This system didn’t only enabled polished research about drug utilization, but also enabled 
investigators and researchers to make more efficient drugs. Researchers can examine statistics 
about a particular medicine against a specific disease, which can lead to solid conclusions about 
the effectiveness of that drug. Pharmacists can make adjustments in drug developing process 
by improving the quantity of certain substances in a drug. 
As discussed concisely about the identification of a drug by ATC codes in section 2.1.4, we 
can develop more understanding of ATC codes by having a look at the following example 
which is also used by WHOCC for the illustration of the structure: 
 
Figure 2.15 Example classification of Metformin [28] 
First level in the ATC code describes Anatomical group, which are divided into 14 categories. 
In the example above, A implies that the drug belongs to Alimentary tract & metabolism group. 
Second level, consisting of two digits, describes the therapeutic group. In the example, code 
A10 describes that the drug is used for the treatment of diabetes. Third level depicts 
pharmacological group and consists of only one alphabetical letter. In the example above, code 
A10 B shows that this particular drug is used in lowering of glucose in the blood. Fourth and 
fifth levels indicate chemical group and chemical substance respectively. In the code A10B A 
02 from the example above, A is indicating that the drug is actually an Biguanides which is 
used to treat type II diabetes. The last two digits, in our example 02, indicates the actual drug 
substance which is Metformin. At every level, there are groups and subgroups to categorize all 
the possible substances and concepts, which are maintained by WHO Collaborating Centre for 






 Implementation and Solution Architecture 
This chapter will include the architecture description of our solution, that is to develop an 
ontological model of FEST and integrate it with other resources to represent DDI and their 
mechanisms. FEST XML model is used in Norway, and is therefore represented in Norwegian 
language, with some of the data having English vocabulary. In our solution, we are also using 
Norwegian vocabulary for the development of ontology (i.e. classes, properties etc.), as it 
meant to integrate with Norwegian health systems. 
To achieve semantic interoperability and to add support for DDI interaction, we used some 
customized classes and relations along with FEST ontology. To represent different mechanisms 
which can trigger a particular drug-drug interaction, we used a set of concepts from DINTO 
ontology and integrated them with our ontology by using different predicates. The figure below 
shows an overview of the architecture of our solution: 
 
Figure 3.1 Structure overview 
The figure above shows an overview of the whole structure of this thesis. Mapping between 
FEST database and ontology is one-to-one, and we have defined certain directions about which 
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resource from FEST will correspond to which component in the ontology. Most of the FEST 
catalogues/resources are represented using UML diagrams which helped us in mapping. All 
the catalogues from FEST such as LegemiddelMerkevare, LegemiddelDose, Interaksjon and 
Diagnose are mapped to corresponding classes in the ontology with same notation. For 
example,  a catalogue to represent drug Interaction, represented as Interaksjon  in FEST, has 
the same notation and is mapped to rdfs:Interaksjon class. All the relevant resources with this 
catalogue such as KatInteraksjon and OppfInteraksjon are also mapped to corresponding 
classes.   
Object properties are used to relate an instance with another instance. Attributes in FEST such 
as CV (coded value), and CS (coded simple) are mapped as to corresponding object properties. 
These attributes belong to some coding system in the FEST database. All the other attributes 
such as name, id, and time are mapped as data properties. The notation we have used for object 
properties and data properties is in accordance with the class that the particular property is 
intended for. For example, we can interpret that property interaksjon.id has its domain as class 
Interaksjon and is only associated with instances of this class. Similar notation is used for 
object properties. 
Cardinality restrictions on different data types from FEST are mapped using cardinalities 
defined in OWL. For example, 1..∞ is mapped  using owl:minCardinality, and 0..1 is mapped 
using owl:maxCardinality which are also presented in a report published by Kilian Kiko und 
Colin Atkinson [29]. In protégé, these assertions can be defined by using keywords such as 
min, max, some, exactly and only.  
The data instances from FEST are mapped to corresponding owl:object in the ontology. Names 
of the objects in ontology are mostly id’s of  particular instances in FEST database. The 
attribute “Composition” is not directly available in OWL or RDF, and has to be mapped by 
using a combination of relations on property. In a paper [30]presented at EGC 2005-Workshop 
Modelling of Knowledge presented by Macaire Ahlonsou, Henri Briand and Fabrice Guillet, 
they exhibited a method to capture composition concept from UML to OWL. A property with 
Transitive and Antisymmetric relation along with cardinality exactly 1 will correspond to the 
composition concept of UML. We have also used the same approach, and property enDelAv is 




Referring to figure 3.1, we can see that patient data is integrated with FEST ontology to 
generate implicit information about possible drug interaction. The classes for patient data along 
with family member history is are defined inside the FEST ontology, and are mapped to the 
existing properties and classes. Optionally, an ontology having data from FHIR servers can 
also be integrated with FEST ontology. For the drug interaction mechanisms, we extended the 
class structure represented in DINTO ontology and integrated it with existing classes and 
properties in FEST ontology.  
We used SPARQL queries to retrieve data from the ontology, and used CONSTRUCT queries 
to insert implicitly generated triples into the ontology in the use case of interaction mechanisms. 
Optionally, we could also use a SPARQL endpoint such as Fuseki to execute SPARQL queries, 
but it is not implemented in this thesis. If the FEST ontology is to be extended afterwards, 
similar methods as described above can be used.  
3.1 Class hierarchy  
To build the FEST ontology, we used protégé 5.2.0, which is the latest version at this moment. 
We will first describe the hierarchy of all the classes and properties, along with their purpose 
followed by description of rules and restriction imposed on particular classes. Mapping 
architecture of particular catalogues from FEST to particular classes and properties is described 
later in the chapter. The figure below shows class hierarchy of FEST ontology: 
 
Figure 3.2 FEST Ontology Class hierarchy 
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The blue arrows represents the property rdfs:hasSubClass. The classes marked blue are the 
main classes in this ontology, and other classes such as LegemiddelformKort are only used 
to represent specific information about a specific entity. For example, the class 
LegemiddelformKort have instances such as tablet, capsule, and powder to represent the form 
of a medicine or substance. Instances of this class are directly referred to from a particular drug 
or substance. The actual coding system for to represent the form of a medicine is defined in 
class Kodeverk.  
The class Legemiddel[3.6] having 4 subclasses, is used to represent drugs related information 
and is used in the process of prescribing a drug. The class Kodeverk[3.14] describes and contains 
all the coding systems used in FEST database and in FEST ontology. For example, a coding 
system with code 7180 is used to identify medicines based on ATC classification. The class 
Diagnose[3.12] is used to aid practitioner in the process of prescription. It contains information 
about the usage of medicine such as recommended dosage, maximum dosage, and approved 
normal dosage for a particular treatment.  
The class Interaksjon[3.15] is used for the identification of all the possible drug interactions 
.For example, if two drugs are prescribed simultaneously, they may lead to an unwanted side 
effect. Such information about the potential interaction is represented in class Interaksjon. 
The other two classes Substans and Substansgruppe are also used in the same context. These 
two classes contains information about the actual substances and group of substances that lead 
to a potential drug interaction. The classes M30Fest and EnkeltoppforingsFest[3.5] are used to 
contain all the catalogues and information about entries made in the system. These classes are 
meant to be used by an API to store and access the information related to a particular entry 
made in the system such as prescription entry, warning entry, and interaction alert entry. 
3.2 Object property hierarchy  
The object properties used in the FEST ontology represent relation between two instances, and 
also imply restrictions and conditions on certain classes. The notations used in this ontology 
follow the same rule that we have used in our paper, that is to use class name along with the 
property name separated by a dot. This enables to distinguish quickly between the property 
usage for human interpretation. For example, Legemiddel.ATC represents an ATC code linked 
with a particular drug and we can quickly differentiate that this ATC code represents 





Figure 3.3 Object property hierarchy 
Figure 3.2 shows a snippet of some of the object properties that are being used in this ontology. 
The properties without any class name behind them are used by multiple classes i.e. the object 
property definerer  is used by instances of class KodeverksInfo to define some elements of 
class KodeverksElement, and the same property is used by instance of class Varseltype to 
define the types of notification. The detailed interpretation of object properties associated with 
classes, along with their domain and range is given in chapter 3. However their complete usage 
with respect to different instances and classes is given in the Appendix B in the form of RDF 
code.  
3.3 Data properties hierarchy 
The data properties we have used, are also following the same notation to achieve simplicity 
and consistency. Different information such as names, id’s, and codes is captured using data 




Figure 3.4 Data property hierarchy 
There are some data properties that have special description for different scenarios. For 
example, the data property interaksjon.relevans is used to classify the potential risk posed by 
a drug-drug interaction. The range of this property is xsd:integer, and a specific integer should 
be used with this property, i.e. if a certain drug interaction is very severe which may lead to 
dangerous side effects, then the code “1” should be used as the range of this property to indicate 
that this particular combination of drugs should be avoided at any cost. Several other similar 
attributes are mapped to data properties using similar method instead of using an object 
property and creating an entire new coding system. The figure below shows the description of 
scenario described above: 
 
Figure 3.5 Mapping of a data property with special conditions 
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3.4 Mapping of FEST catalogues to FEST ontology 
This sub section explains in detail the mapping from FEST XML database to our FEST 
ontology.. Refer to Appendix A for description of terms. 
3.5 Mapping of M30FEST 
M30 FEST contains all the catalogues, and in our ontology we have mapped it to a class 
M30Fest. Refer to the figure 2.13, there we have 14 catalogues to represent different details 
from drug information to prescription information. As described in chapter 1, in this ontology 
we are not focusing on KatRefusjon, KatVilkår, KatByttegruppe, and KatDosering. All the 
UML diagrams are taken from “FEST Implementeringsveiledning” document [25]. The UML 
structure of M30FEST along with its corresponding mapping to the ontology is shown in the 
figure below: 
 
Figure 3.6 Catalogue mapping to Classes 
The attributes of M30 FEST to represent date and time are mapped to data property 
M30Fest.hentetDato. To represent all the catalogues, we have used the property inneholder 
which is both transitive and antisymmetric and its cardinality is placed to be exactly “1” to 
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from the composition relation between M30Fest and catalogues. This concept of composition 
translation into protégé is presented by Macaire Ahlonsou, Henri Briand, and Fabrice Guillet 
in a paper [30]. Every catalogue may contain its relevant entry (oppf<className>) class. This 




Figure 3.7 Example of mapping from catalogue 
Figure 3.7 shows that every instance of class KatLegemiddelVirkestoff will include an 
instance of class OppfLegemiddelVirkestoff through the property inneholder. The class 
OppfLegemiddelVirkestoff is a subclass of EnkeltoppforingsFest, and inherits all the 
properties from parent class, which are used to record the time, status and id of an entry.  
3.6 Mapping of EnkeltoppforingsFest  
This class is used to store the record of entries, i.e. prescription. For example, every instance 
of class OppfLegemiddelVirkestoff will include an instance of class LegemiddelVirkestoff 
which is used to describe the actual substance. As described by Norwegian Medicines Agency, 
every new entry will have a new and unique entry-id, time and activity status. If an application 
(web, API etc. ) is made based on this ontology, we will be using this mapping to store every 
new entry. The figure below shows the UML structure of EnkeltoppforingsFest and its 




Figure 3.8 Mapping of EnkeltoppforingsFest 
Figure 3.8 shows that all the classes used for the entry of specific source are defined as 
subclasses of EnkeltoppforingsFest. The attributes shown in the UML diagram are mapped 
to this class by using data properties. These data properties are used as conditions on the class 
EnkeltoppforingsFest. The table below summarizes the purpose and definition of data 
properties used with class EnkeltoppforingsFest: 
Property Domain  Range  Short Explanation 
enkeltoppforingFEST.id EnkeltoppforingsFest xsd:string Unique id, used for 
identification  
enkeltoppforingFEST.status EnkeltoppforingsFest xsd:string Active/Non-active 
entry 
enkeltoppforingFEST.tidspunkt EnkeltoppforingsFest xsd:dateTime Time and date of an 
entry 
 
Table 3.1 Properties for class EnkeltoppforingsFest 
 
3.7 Mapping of class Legemiddel 
To address the mapping of actual catalogues, we will start with the explanation of class 
Legemiddel which is used to store every information related to a drug or substance. It contains 
all the medicines that can be prescribed by the practitioner in Norway, including details of 
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substances, manufacturers, packaging, and dosing. The figure below shows the class structure 
of Legemiddel : 
 
Figure 3.9 Legemiddel class hierarchy 
The class Legemiddel, as shown in the figure above has four subclasses which are described 
later in the chapter. Refer to section 4.1 for an example of a Legemiddel instance. It should be 
noted that the class Legemiddel itself does not contain any drug or substance, but the 
subclasses that are associated with this class are used for the representation of a particular drug 
and relevant information such as dosage, branded medicine, and packaging. The subclasses 
LegemiddelDose and LegemiddelPakning are essential in prescription and representation of 
a specific branded drug or substance, and therefore they are defined as subclasses of 
Legemiddel similar to FEST XML structure. 
We have mapped navnFormStyrke, reseptgruppe, and typeSoknadSLV to data properties 
having range as xsd:string. It is to asserted that reseptgruppe, and typeSoknadSLV can also be 
mapped using an object property similar to the mapping of ATC. Attributes like ATC, 
legemiddelformKort, and preparattype are mapped as object properties to Legemiddel.ATC, 
Legemiddel.legemiddelformKort, and Legemiddel.preparattype respectively, as shown in the 
figure 3.9. A particular medicine (an instance of Legemiddel) is identified by using a reference 
to ATC coding system (an instance of class KodeverksElement), which has certain attributes 
and references for further identification of the drug or substance. Please refer to section 3.14 
for further explanation of class KodeverksElement and different coding systems. 
Similarly, for the identification of the type of drug or substance, a reference is made to an 
instance of class KodeverksElement having a different coding system. The cardinality of 
different properties is mostly kept same as was defined by Norwegian Medicines Agency while 
developing FEST database, and mapping is achieved by assigning certain conditions on a class. 
In the figure 3.9, property assertion legemiddel.ATC max 1 KodeverksElement donates that the 
class Legemiddel cannot have a reference to more than one instance of KodeverksElement. 
39 
 
Similarly, keywords some and exactly are used for different restrictions. The table below 
summarizes all the properties associated with class Legemiddel.  
Property Domain  Range  Short Explanation 
legemiddel.ATC Legemiddel ATC ATC code for 
identification 
legemiddel.legemiddelformKort Legemiddel LegemiddelformKort Used to describe 
form of a medicine 
legemiddel.preparattype Legemiddel PreparattypeLegemiddel Used to identify the 
formulation of a 
medicine such as 
medicine, vaccine, 
and natural medicine  
 
legemiddel.navnFormStyrke 
Legemiddel xsd:string A combination of 
name, type, and 
strength of 
drug/substance 
legemiddel.reseptgruppe Legemiddel xsd:string Used to describe 
receipt group of a 
medicine 
legemiddel.typeSoknadSlv Legemiddel xsd:integer Used to identify the 
application dispenser  
Table 3.2 Properties for class Legemiddel 
 
3.8 Mapping of class LegemiddelVirkestoff 
The class LegemiddelVirkestoff is used to identify all the active medicine 
substances/ingredients that can be prescribed in Norway. When practitioner needs to write a 
substance or an ingredient or a combination of different ingredients, the details of that is 
available in the class LegemiddelVirkestoff. This class inherits all the properties that we have 
associated with class Legemiddel such as ATC code information, and type of substance. The 
figure below shows the UML architecture of resource LegemiddelVirkestoff along with its 




Figure 3.10 Mapping of LegemiddelVirkestoff 
This class also has direct references to the class LegemiddelMerkevare and 
LegemiddelPakning, and is mapped through object properties 
legemiddelVirkestoff.refLegemiddelMerkevare and legemiddelVirkestoff.refPakning 
respectively. This reference makes it possible to identify the brand and packaging type 
associated with the particular medicine or substance. By using this reference through an object 
property, we can also query for the particular brand a substance may belong to. The properties 
and cardinality restrictions that we have placed on the class LegemiddelVirkestoff are shown 




Figure 3.11 Cardinality restrictions on class LegemiddelVirkestoff 
The figure shows that this class is a part of exactly one OppfLegemiddelVirkestoff, which is 
used for entry purpose as described earlier. This class may also include some instances 
belonging to class SortertVirkestoffMedStyrke and SortertVirkestoffUtenStyrke which are 
used to store information about substances with or without a specific strength. The mapping to 
these classes is done by using the object property inneholder. The table below summarizes the 
details of properties associated with class LegemiddelVirkestoff. 
Property Domain  Range  Short 
Explanation 
legemiddelVirkestoff.id LegemiddelVirkestoff xsd:string Used for 
identification 
of a medicine  
legemiddelVirkestoff. 
refLegemiddelMerkevare 








Table 3.3 Properties for class LegemiddelVirkestoff 
 
3.9 Mapping of class Virkestoff 
The class LegemiddelVirkestoff, as described earlier, contains information about the active 
ingredients that can be prescribed or substances that can be used in therapy. The actual 
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information about a particular substance/ingredient however resides in the class Virkestoff, 
which has all the information such as name of the active substance, strength of the substance, 
dosage measuring parameters, and reference to therapy related substances 
(LegemiddelVirkestoff). Mapping of class Virkestoff to our ontology along with its 
corresponding UML structure is shown in the figure below: 
 
Figure 3.12 Mapping of class Virkestoff 
Figure above shows similar mapping from KatVirkestoff to OppfVirkestoff as we have 
described earlier. It is to be noted that we have not mapped the class Virkestoff as a 
medicine/drug, because as we explained earlier, substances are not actual drugs but are used to 
prescribe the drugs of a particular brand or packaging. In medical field also, practitioners 
usually prescribe using formulas and substances, as it is very difficult to remember the names 
of the brands containing a particular substance. The attributes like name, id, and English name 
are mapped to data properties, while reference to an actual prescribe-able substance is mapped 
by using the object property typeVirkestoff.refVirkestoff. This object property associates 
instances of class Virkestoff with the instances of class LegemiddelVirkestoff. The 




Figure 3.13 Cardinality restrictions on class Virkestoff 
 
Every instance of class Virkestoff has a reference to instances of LegemiddelVirkestoff, 
because one substance may represent different drugs that can be prescribed. Every substance 
with some strength depends upon the actual Virkestoff, as mapped by property avhengigAv. 
It can also be seen in the picture that substance with a strength have references to different 
instances such as EnhetForPakning7452, and MaleenhetForPakning9090. These attributes 
are defined as coding systems in the class Kodeverk. 
Property Domain  Range  Short Explanation 
typeVirkestoff.id TypeVirkestoff xsd:string Used for identification 
and reference(optional) 
typeVirkestoff.navn TypeVirkestoff xsd:string Name of the substance 




TypeVirkestoff LegemiddelVirkestoff Reference to actual 
medicine including this 
substance 
Table 3.4 Properties for class typeVirkestoff 
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3.10 Mapping of class LegemiddelMerkevare 
LegemiddelMerkevare class is used when certain brands are to be identified, which are 
associated with a particular substance(an instance of LegemiddelVirkestoff). This class 
contains all the information related to a brand such as name of the brand, type of medicine, 
taste, and manufacturer information. The figure below shows how we mapped this catalogue 
to the corresponding class in our ontology along with UML structure: 
 
Figure 3.14 Mapping of LegemiddelMerkevare 
Attributes such as id, vernaven, and legemiddelFormLang are mapped to corresponding data 
properties with range as xsd:string. Mapping to particular catalogues such as 
SortertVirkestoffMedStyrke and SortertVirkestoffUtenStyrke is achieved through the 
object property Inneholder, and this mapping is used to point towards actual instance of 
ingredients/substances (Virkestoff) that are connected with these classes. It is also noticeable 
that we didn’t defined a separate class to represent the product information connected with this 
class, as it is done in the actual FEST UML architecture. Instead we used the data properties 
legemiddelMerkevare.produktInfo.produsent, legemiddelMerkevare.produktInfo.refProdukt, 
and legemiddelMerkevare.produktInfo.varselTrekant to store this information. Because it is a 
subclass of Legemiddel, inherited properties from this class are also present in this class. The 




Figure 3.15 Cardinality restrictions on class LegemiddelMerkevare 
There is no direct reference from this class to the class LegemiddelPakning, and to refer to 
that class we have to use another class PakningsInformasjon associated with 
LegemiddelPakning. We propose using a direct reference from class LegemiddelMerkevare 
to LegemiddelPakning to reduce the parsing of information, but we haven’t implemented this 
in our ontology to maintain the coherence with the actual structure of FEST, as the ontology is 
meant to import the real data from FEST database. The properties associated with class 
LegemiddelMerkevare are summarized in the table below: 
Property Domain  Range  Short Explanation 





LegemiddelMerkevare xsd:string Detailed description 
of type   












LegemiddelMerkevare xsd:string Reference for the 
real name of 
medicine in form of 
string (not branded) 
legemiddelMerkevare.produktInf
o.varselTrekant 
LegemiddelMerkevare xsd:boolean Used to identify 
whether medicine 
has a triangle mark 
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Table 3.5 Properties for class LegemiddelMerkevare 
3.11 Mapping of class LegemiddelPakningMerkevare  
The class LegemiddelPakningMerkevare is mainly used to capture information related to the 
packaging of a branded medicine (LegemiddelMerkevare). Different parameters such as 
packaging id, size, and design of packaging are  described in this class. The figure below shows 
the mapping of resource LegemiddelPakningMerkevare to our ontology along with existing 
UML structure: 
 
Figure 3.16 Mapping of class LegemiddelPakningMerkevare 
Every instance of class LegemiddelPakning includes an instance of class 
PakningsInformasjon which is used to describe the physical nature of packaging. There is 
also a reference from class PakningsInformasjon to the actual brand 
(LegemiddelMerkevare) and is mapped through property 
pakningsinformasjon.refLegemiddelMerkevare as shown in the figure 3.16 above. The classes 
with codes 7452 and 7449 are defined in class Kodeverk, and are coding systems to describe 
dosage and packaging type. The cardinality restrictions on the class LegemiddelPakning  are 




Figure 3.17 Cardinality restrictions on LegemiddelPakning 
Every instance of class LegemiddelPakning should have a maximum of 1 id, which is 
primarily used for the identification of packaging. Figure 3.17 also shows that every instance 
of class LegemiddelPakning includes some of the instances of PakningsInformasjon which 
further describe the nature of packaging. The table below summarizes the properties associated 
with class LegemiddelPakning: 
Property Domain  Range  Short Explanation 
legemiddelpakning.id LegemiddelPakning 
 










LegemiddelPakning xsd:string Used to describe 
recommended 
temperature  
legemiddelpakning.varenr LegemiddelPakning xsd:integer Unique item number. 
pakningsinformasjon.antall Pakningsinformasjon xsd:integer Used to describe total 
number of items in 
packaging. 





Pakningsinformasjon xsd:integer Used to describe Size 
of the package in 
terms of quantity 





Used to describe unit 
of packaging such as 







Used to describe the 
type of packaging such 





Reference to the 
branded medicine 
which this packaging 
belongs to.  
Table 3.6 Properties for class LegemiddelPakning 
 
3.12 Mapping of class LegemiddelDose 
The class LegemiddelDose contains all the information related to dosage quantity of a branded 
medicine (LegemiddelMerkevare). This catalogue/source helps in determining the dosage of 
a particular medicine that can be prescribed. It inherits all the properties from the parent class 
Legemiddel. The figure below shows the mapping of class LegemiddelDose to FEST ontology 
and its corresponding UML structure defined by Norwegian Medicine Agency. 
 
Figure 3.18 Mapping of class LegemiddelDose 
In the figure above, classes EnhetOrdinering and Pakningstype7449 are coding systems 
defined under the parent class Kodeverk. Every instance of class LegemiddelDose has 
association with instances of these classes for the description of packaging type and dosage. 
There are direct references from class LegemiddelDose to the class LegemiddelPakning and 
LegemiddelMerkevare. These references are mapped using object properties 
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Legemiddeldose.refLegemiddelPakning  Legemiddeldose.refLegemiddelMerkevare 
respectively. The conditions we have imposed on the class LegemiddelDose are shown in the 
figure below: 
 
Figure 3.19 Cardinality restrictions on class LegemiddelDose 
The figure highlights that any instance of class LegemiddelDose have exactly 1 reference to a 
brand, and minimum 1 reference to a packaging. The cardinality for the unit of dosage, mapped 
as legemiddeldose.enhetOrdinering in the figure above, is not restrictive because a dosage can 
have different units leading to same dosage quantity such as 2 drops, 1 ml, and 1 capsule. A 
detailed description of the properties associated with class LegemiddelDose is shown in the 
table below: 
Property Domain  Range  Short Explanation 




LegemiddelDose xsd:integer Same as in packaging  
legemiddeldose.enhetOrdiner
ing 
LegemiddelDose EnhetOrdinering Used to identify unit of 
dose i.e. capsule, drop 
etc.  
legemiddeldose.pakningstype LegemiddelDose Pakningstype7449 Same as used for 
describing type of 
packaging 
legemiddeldose.refPakning LegemiddelDose LegemiddelPakning Reference to all 
packaging which 





Reference to branded 
medicines belonging 
to this dose. 
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Table 3.7 Properties for class LegemiddelDose 
 
3.13 Mapping of class Diagnose 
The class Diagnose is mainly used to support the practitioner during prescription process, 
giving him information about medicines that are relevant in certain conditions. Practitioners 
are generally not able to memorize all the medicines that can be prescribed, in this situation 
class Diagnose is used to give them available choices related to certain diagnoses. The UML 
model defined in FEST is shown in the figure below along with the corresponding mapping of 
class Diagnose in the ontology: 
 
Figure 3.20 Mapping of class Diagnose 
As used to store information about possible alternatives for a diagnose, the structure of mapping 
is defined as Diagnose --> Behandling --> LegemiddelForslag --> DoseringForslag ==> 
GodkjentMaksimaldose, GodkjentNormaldose through the properties shown in the figure 
above.  The class LegemiddelForslag has a direct reference to class LegemiddelMerkevare 
and LegemiddelVirkestoff, and is mapped through the properties 
LegemiddelForslag.refLegemiddelMerkevare and 
LegemiddelForslag.refLegemiddelVirkestoff respectively. These mappings are used to identify 
the brand and packaging of proposed medicine in a particular diagnose. The property 




Figure 3.21 Cardinality restrictions on class Diagnose 
Every instance of class Diagnose can have more than 1 treatment suggestion (Behandling) 
because different patients may require a different treatment based on his health record. This is 
achieved by defining Diagnose definerer some Behandling on the class Diagnose as shown in 
the figure 3.17. Similarly, a particular treatment may also include several medicine 
recommendations, and this is achieved by defining Behandling definerer some 
LegemiddelForslag on the class Behandling. Furthermore, a recommended medicine may 
also have several dosage possibilities in terms of quantity, severity, etc. This is achieved by 
defining LegemiddelForslag definerer some DoseringsForslag on the class 
LegemiddelForslag.  A direct reference from the class LegemiddelForslag is also mapped 
through the properties shown in figure 3.17. A detailed description of class properties 
associated with class Diagnose is shown in the table below: 
Property Domain  Range  Short Explanation 
diagnose.id 
 
Diagnose xsd:string Unique ID used for the 
identification 




diagnose.bruksomrade Diagnose xsd:string Used to describe which area is 
treatment used for. i.e. heat 
stroke, fever etc. 
behandling.beskrivelse 
 




LegemiddelForslag xsd:string Used to describe conditions of 
treatment doctor should 
consider such as lever failure, 
and low dose in start. 
legemiddelForslag.virkesto
ffNavnForm 
LegemiddelForslag xsd:string Used for text description of 
name and form of substance 






If reference to actual 
drug/substance is not present, 
then a reference to branded 






Reference to actual 
drug/substance that can be 
prescribed under this dose. 
doseringsforslag.behandli
ngsfase 
DoseringsForslag xsd:string Used to describe the treatment 
phase of dosage 
recommendation i.e. start 
phase, according to 
requirement etc.  
doseringsforslag.varighet DoseringsForslag xsd:string Used to describe the duration 
of treatment in terms of days, 
weeks or months. 
Table 3.8 Properties for class Diagnose 
 
3.14 Mapping of class VarselfraSLV 
The class VarselfraSLV is mainly used by Norwegian Medicines Agency to send important 
notifications and warnings about drugs, brands, interactions etc. to different stakeholders which 
are using FEST database. An ontological version of this class, along with class Kodeverk, has 
been implemented as an ontology [3], and the data is published over the web. We have used a 
different approach while mapping this class to our FEST ontology, because we are also 
mapping this class to the other catalogues and classes in our ontology. The UML structure of 




Figure 3.22 Mapping of class VarselfraSLV 
We defined a main class VarselFraSLV to contain all the three classes VarselSLV, Lenke, and 
Referanseelemt. The main class VarselFraSLV doesn’t have any attributes to inherit and 
works as a container for three classes. The classes Visningsregel7442 and Varseltype7441 are 
coding systems defined under the main class Kodeverk, and are used to capture information 
related to viewing authority and warning type respectively. Every instance of class VarselSLV 
is connected to an instance of reference element and link. The restrictions on the class 
VarselSLV are shown in the figure below: 
 
Figure 3.23 Cardinality restrictions on class VarselSLV 
54 
 
Every instance of class VarsleSLV can only belong to one type of warning, therefore it is 
mapped with the property VarselSLV.type exactly 1 Varseltype7441. Any warning should also 
be viewable by at least one stakeholder, otherwise any warning is meaningless, this mapping 
is achieved by the property VarselSLV.visningsregel min 1 Visningsregel7442. A detailed 
description of the properties associated with class VarselSLV and its associated classes is 
shown in the  table below: 
Property Domain  Range  Short Explanation 
varselSLV.overskrift VarselSLV xsd:string Used to describe heading of the 
warning/notification. 
varselSLV.varseltekst VarselSLV xsd:string Used to describe the 
notification/warning in detail. 
varselSLV.fraDato VarselSLV xsd:dateTime Use to describe the date/time 
from which the notification is 
effective. 
varselSLV.type VarselSLV Varseltype7441 Used to describe type of 
notification/warning such as 
Safety notice, general notice, and 
shipment failure. 
varselSLV.visningsregel VarselSLV Visningsregel7442 Used to describe which 
stakeholder should see the 
notification. 
lenke.beskrivelse Lenke xsd:string Used to describe the purpose of 
link. 
lenke.URL Lenke xsd:string Used to capture actual URL link. 
Table 3.9 Properties for class VarselSLV 
 
3.15 Mapping of class Kodeverk 
The catalogue Kodeverk represents all the coding systems currently utilized by FEST database. 
These coding systems are maintained by Norwegian directorate of eHealth. An ontology to 
represent the Kodeverk catalogue is also developed by FEST management, but in our mapping 
we used a different approach from that ontology to maintain the coherence between the 
structure of our ontology. The figure below shows the mapping between catalogue Kodeverk 




Figure 3.24 Mapping of class Kodeverk 
We have used a slight different approach while mapping the class Kodeverk by defining a main 
class Kodeverk having the subclasses KodeverksInfo and KodeverksElement which are also 
visible in the UML structure. Any instance of class KodeverksElement is defined by an instance 
of class KodeverksInfo, and the mapping is accomplished using the property definerer. We can 
observe the class Term  in UML structure, but in our approach we have mapped these attributes 
by using data properties and extending the notation of KodeverksElement. Different property 
assertions on the class KodeverksInfo and KodeverksElement are shown in the figure below: 
 
Figure 3.25 Cardinality restrictions on class Kodeverk 
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This class does not have reference to any other class, but other classes such as 
LegemiddelVirkestoff, and LegemiddelMerkevare use this class to refer to certain elements 
defined under different coding systems. A coding system Varseltype7441 will have different 
instances to represent different type of warnings, and all those warning instances may also have 
further attributes that are shown in the figure 3.25. Different properties associated with class 
Kodeverk are summarized in the table below: 
Property Domain  Range  Short Explanation 
kodeverksInfo.id 
 
KodeverksInfo xsd:string A unique ID for 
identification of coding 
system. 
 
kodeverksInfo.merknad KodeverksInfo xsd:string Used to insert comments 
to a particular coding 
system. 
kodeverksInfo.kortnavn KodeverksInfo xsd:string Short name of coding 
system. 
kodeverksInfo.betegnelse KodeverksInfo xsd:string Used to describe actual 
specification of coding 
system 
kodeverksInfo.ansvarligUtgiver KodeverksInfo xsd:string Used to describe 
responsible publisher of 
coding system. 
kodeverkselement.id KodeverksElement xsd:string A unique ID Used to 
identify an coding 
element inside FEST 
ontology. 
kodeverkselement.kode KodeverksElement xsd:string Used to describe actual 
code of element given by 
the publisher. 
kodeverkselement.term KodeverksElement xsd:string Name or term of the 
element given by 
publisher of coding 
system. 
kodeverkselement.sprak KodeverksElement Sprak3303 Used to specify which 
language is element 
defined in. 
Table 3.10 Properties for class Kodeverk 
 
3.16 Mapping of class Interaksjon 
Catalogue Interaksjon is of great importance, as we propose a use case to generate implicit 
data from the existing data for safe medication. We have also proposed in thesis to represent 
Interaction mechanisms by integrating FEST Ontology (particularly Interaksjon class) with 
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DINTO ontology. The figure below shows the mapping of Interaction catalogue to our 
ontology: 
 
Figure 3.26 Mapping of Interaksjon 
Most of the attributes of catalogue Interaksjon are represented as data properties with range 
as string. The class Interaksjon contains Substansgruppe and Substans class, and are 
mapped through object property inneholder, which is used as a condition in the class structure 
of Interaksjon. Figure below shows the cardinality restrictions along with other property 
conditions that we have mapped from the FEST to the class Interaksjon: 
 
Figure 3.27 Cardinality restrictions on class Interaksjon 
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We also mapped the Referanse class from the UML as an object property by extending 
property notation as interaksjon.referanse.kilde and interaksjon.referanse.URL. These 
properties are used to capture the source from where the information about the drug interaction 
is taken. Every Interaksjon instance will include 2 or more substance groups, and every 
substance group will have minimum 1 substance instance. Suppose there are two substance 
groups A and B. Group A have 1 substance, and group B has 3 substances in it, this entails that 
the 1 substance from group A will have an interaction with all the three substances of group B. 
Every substance have a direct reference to class  typeVirkestoff which is identified further 
using ATC coding system. The properties such as relevans, kildegrunnlag, and visningsregel 
are mapped as data properties which could also have been mapped as object properties, as 
described in section 3.3, by defining their corresponding coding system in the class Kodeverk.   
The table below summarizes the properties associated with class Interaksjon: 
Property Domain  Range  Short Explanation 




interaksjon.forklaring Interaksjon xsd:string a replacement for 
“interaksjon.mekanis
me” to describe the 
cause of interaction in 
textual form. 






Interaksjon xsd:string Used to specify the 
source of how 
interaction was 
discovered.   
interaksjon.kliniskKonsekvens Interaksjon xsd:string Used to specify 
clinical consequences 
of interaction.  





Interaksjon xsd:string Used to specify when 
an interaction should 
be handled.  
interaksjon.referanse.kilde Interaksjon xsd:string Reference to the 




interaksjon.referanse.URL Interaksjon xsd:string Link/URL to the 
source. 
interaksjon.visningsregel Interaksjon Visningsregel7442 Used to specify 
stakeholder who 
should see this 
interaction. 
interaksjon.mekanisme  Interaksjon DDI_Mekanisme Used to integrate 
with drug interaction 
mechanisms. 
substansGruppe.navn SubstansGruppe xsd:string Used to describe 
name of the 
substance group. 
substans.ATC Substans ATC Used to identify 
substance using ATC 
code defined in 
coding system. 
substans.navn Substans xsd:string Used to specify name 
of the substance as in 
coding system. 




Table 3.11 Properties for class Interaksjon 
 
3.17 Mapping of FEST ontology for Drug interaction mechanisms 
Drug Interaction mechanism describe the process and means by which a particular drug 
interaction is provoked. These mechanisms can help in classification of interactions on the 
basis of procedure which can be valuable in identifying and scrutinizing the similar 
characteristics between interactions. Two drugs can generate undesired results If they are 
prescribed simultaneously. Drug interaction mechanisms are generally divided in two types, 
Pharmacodynamic and Pharmacokinetic mechanisms. Former refers to an interaction where 
two drugs add up together to give an additive or adverse side effects. While latter indicates an 
interaction where one of the drug affects the efficiency of the other drug. As presented in an 
article by Philip Hansten and John Horn, Pharmacokinetic interactions may have further 
classifications such as Inhibition of Absorption, Enzyme Inhibition Increasing Risk of 
Toxicity, Enzyme Inhibitors Resulting in Reduced Drug Effect, Enzyme Induction Resulting 
in Reduced Drug Effect, Enzyme Induction Resulting in Toxic Metabolites, and Altered Renal 
Elimination [31]. While Pharmacodynamic interactions may also be further classified into 
Additive Pharmacodynamic Effects, and  Antagonistic Pharmacodynamic Effects [31]. We are 
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not concerned with the biological effects of these mechanisms, but instead, we present a 
method for the classification of drug interactions in our ontology.  
As we argued about the benefits of representing FEST data as an ontology an how it can be 
combined with existing ontologies to develop more advanced support systems. We integrated 
the drug interaction mechanism structure from DINTO ontology with our FEST ontology by 
using the existing attribute in FEST database that is interaksjon.mekanisme. This particular 
attribute is currently used to accept data as a string by which merely states about the cause of 
particular interaction. For example, one of the interaction in FEST database points towards the 
mechanism of interaction by stating that “substance A increases the metabolism of substance 
B” which is recorded under the property interaksjon.mekanisme. In contrast to that, We have 
used similar method as represented in DINTO ontology, for the representation of interaction 
mechanisms, and have integrated it into FEST ontology that will result not only in a more 
sophisticated classification of interaction mechanism, but also in identifying the mechanisms 
which can incur similar interactions. The figure below shows the class structure of Interaction 
mechanism: 
 
Figure 3.28 class hierarchy for Interaction Mechanisms 
In this thesis, we are not concerned about the biological or clinical rules and effects of these 
mechanisms, therefore subclasses of Pharmacodynamic and Pharmacokinetic doesn’t have any 
rules or restrictions on them. We can, in future, use these classes to define proper conditions 
for a particular mechanism, and all the interaction in FEST database can be classified under 
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these classes. We also have Farmakokinetisk_Interaksjon and 
Farmakodynamisk_Interaksjon defined as subclasses of Interaksjon. The mechanism 
defined above will result in these interactions. The figure below represents the conditions that 
should be fulfilled in order to be classified as an Pharmacodynamic or Pharmacokinetic 
interaction: 
 
Figure 3.29 Well defined conditions for interaction classification 
We will again emphasize that the conditions might not be biological correct, but the actual 
representation with accurate conditions will be similar to the figure 3.29. If an interaction has 
instances of group 1 and group 2, and mechanism behind it is Pharmacodynamic, then that 
interaction can be classified as an Pharmacodynamic interaction. Similar conditions are 
imposed on Pharmacokinetic interaction. We took in consideration the existing information 
connected with the interaksjon.mekanisme in FEST, and that is now represented by using 




 RESULTS  
In this chapter, we will describe the different results we can achieve using SPARQL queries. 
We have used SPARQL plugin for protégé to demonstrate the execution of queries. A SPARQL 
endpoint such as Fuseki can also be used for the same purpose. These results will also help in 
further understanding the mapping between different classes that we have described in chapter 
3. It is to be noted that we have not imported all the instances from FEST database, as this 
would be another project. Instead, we have mapped a limited amount of instances from 
different classes to demonstrate different use cases such as drug interactions, and interaction 
mechanisms.  
4.1 SPARQL queries on LegemiddelVirkestoff  
The class LegemiddelVirkestoff, as described earlier, is used to identify all the medicines that 
can be prescribed in Norway. If we simply want to retrieve all the medicines that can be 
prescribed, we can use a simple query shown in the figure below: 
 
Figure 4.1 query result for instances of LegemiddelVirkestoff 
 
This will fetch us all the drugs that are of type Legemiddel, or in other terms, all the instances 
that belong to Legemiddel class. At the moment, for the purpose of demonstration, we have 
only two instances of class LegemiddelVirkestoff which are also shown in the RDF graph in 




Figure 4.2 RDF graph for instances of Legemiddel 
We can fetch the details of a particular drug (instance of Legemiddel) such as ATC code, name, and 
reference to other classes by using a simple query shown in the figure below along with the 
corresponding results: 
 
Figure 4.3 query result for a particular instance of Legemiddel 
The instance LegemiddelVirkestoff_11 have two references to LegemiddelMerkevare (marked 
as blue), and two references to the instances of class LegemiddelPakning (marked as green), 
as shown in the figure 4.3. This implies, that the drug LegemiddelVirkestoff_11 is available in 
two different packages, and two different brand names. The drug itself is identified by the ATC 
code “J02AC01”. Please refer to figure and for the specifications of referred instances. The 




Figure 4.4 RDF graph for Legemiddel instance 
The referred instances belong to class LegemiddelPakning and LegemiddelMerkevare. We can 
also notice that LegemiddelVirkestoff_11 is identified using J2AC01 which is defined under 
the ATC coding system in class ATC.  
4.2 SPARQL queries for LegemiddelMerkevare 
An instance of class LegemiddelMerkevare describes a particular brand of the medicine. As 
shown in the figure 4.3, one medicine can be available in the market having different brand 
names. All the instances of class LegemiddelMerkevare can be accessed using a query similar 
to the query shown in figure 4.1, and only difference would be to replace 
:LegemiddelVirkestoff with :LegemiddelMerkevare. To retrieve all the information related 




Figure 4.5 Query result for an instance of LegemiddelMerkevare 
The instance of LegemiddelMerkevare with ID “ID_A2BAA17E-231F-4891-B704-
4FB83DD8A737”, as shown in the figure above, is the same instance that is being referred in 
figure 4.3 by LegemiddelVirkestoff_11 instance. The drug  Itrakonazol 
(LegemiddelVirkestoff_11) is available under the brand shown in figure above, and is 
produced by Janssen-Cilag AS. An RDF graph of the result is shown in the figure below: 
 
Figure 4.6 RDF graph LegemiddelMerkevare instance 
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The graph shows the reference to different instances that we have also retrieved using the query 
in figure 4.5. The instances Legemiddel, pakning_3388, and Kapsel, as shown in the figure 
above ,belong to the corresponding coding systems, which are mainly defined in the class 
Kodeverk. 
4.3 SPARQL queries for LegemiddelPakning 
Similar to the queries shown in section 4.2 and 4.3, we can also retrieve the information related 
to a particular instance of class LegemiddelPakning. We can also retrieve the information 
about the actual drug or substance which is being represented by a particular packaging. The 
figure below shows the SPARQL query to get such information: 
 
Figure 4.7 Query result for retrieving drug information through Packaging 
The query shown above identifies all the ATC codes associated with the instance of 
LegemiddelPakning, shown as ?drug. Because only one instance of ATC code is associated, 
which is J02AC02, the information for only that code is retrieved. The value of “S” denotes 
the coding system under which the instance “J02AC02” is defined. And “7180” denotes the 
coding system for ATC classifications. We can also check through class LegemiddelMerkevare 
or LegemiddelPakning about the potential drug-drug interaction. This is not explicitly stated in 
the FEST database that a particular brand may lead to some interaction, but using SPAQL 
queries we can generate that result. An example of a similar query is shown in the section. 
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4.4 SPARQL queries for Drug Interactions 
To check for an interaction between two drugs we can retrieve information from the class 
Interaksjon. All the interactions are listed under this class as instances, and we can check for 
an interaction between two specific drugs by using the query shown in figure below: 
 
Figure 4.8 Query for checking drug-drug interaction 
The substances Irinotekan and Itrakonazol belong to two different substance groups, and both 
of those Substans groups, when combined, lead to a potential drug interaction. The query 
shown in the figure above also shows all the details of the particular interaction such as 
reference, consequences and relevant precaution. It can also be seen in the figure above that 
there is a particular mechanism (eksempel_pharmacodynamicMekanisme) which has triggered 
this interaction. We have used the FEST property Interaksjon.mekanisme to map this 
information which is not defined in FEST database. More information about drug mechanism 
is given in the section . We can combine and customize this query with previous queries to 
generate results about whether a particular brand may lead to an interaction. 
A substance group may include more than one medicines which means that all those medicines 





Figure 4.9 query result for checking all the potential interactions 
We first retrieved the group of Flukonazol, and then checked whether that group has interaction 
with other groups. In case of true statement, we checked further for all the groups that particular 
interaction belongs to. Then we retrieved the information about specific substances of the 
second group. We used MINUS in this query to exclude the instances of first group. The result 
in figure 4.9 shows that the drug Flukonazol have an interaction with both Amprenavir and 
Fosamprenavir, which are instances of the same group. By Combining and customizing the 
query shown in figure 4.8 with this query, we can further retrieve the information of the 
interaction itself. The figure shown the RDF graph of the case presented above and confirms 
the query results too: 
 
Figure 4.10 RDF graph for drug interaction 
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4.5 Query results for Drug Interaction Mechanisms  
In section we have described the methodology for the classification of interaction mechanisms. 
Now, if there is an interaction which satisfies the necessary conditions for the classification, 
then that interaction should be classified correctly. The figure below shows the results of 
reasoner which classifies Interaksjon_1 instance as Pharmacodynamic interaction. 
 
Figure 4.11 Reasoner result for classification of Interaction 
The instance Interaksjon_1 includes some medicines from group 1, and some medicines from 
group 2, and is also caused by an instance of Farmakodynamisk_mekanisme, therefore it has 
been classified correctly under the category of Pharmacodynamic interaction. For the details 
of Interaksjon_1 please refer to  
4.6 Query results for drug interaction in context with patient’s family member 
history 
We created a class structure and integrated it with FEST ontology to generate implicit data 
about possible drug-drug interaction by examining the data related to patient and his family 
member history. In the FEST database there is a class InteraksjonIkkeVurdert, which we 
have used to integrate FEST ontology with the case specified. Any interaction which is not 
currently stated in FEST database will be defined under this class. If two or more family 
members of a patient were prescribed a combination of medicines, and their journal have a 
record that they showed some unwanted side effects, but those medicines were not expected to 
generate any side effects. In this case, the patient should be examined before giving same 
combination of drugs as there may be case of genetical reaction to those drugs. This case has 
been presented in presented in our research paper. The figure below shows the RDF graph of 




We used the SPARQL CONSTRUCT  query to generate implicit triples about unknown DDI’s 
by examining the existing data. For example, suppose that father of Ole Nordmann, having a 
heart disease, was prescribed a combination of drugs Itrakonazol and Fosamprenavir; and his 
brother, having similar disease, was also prescribed Itrakonazol and Amprenavir. Both 
Amprenavir and Fosamprenavir belong to same substance group in FEST.  Their patient history 
exhibit that both of them suffered from some side effects, possibly a DDI. But this DDI is not 
explicitly stated in the database nor the drugs were supposed to exhibit a reaction. A 
hypothetical diagnose can be linked to such a situation that genes of the concerned persons may 
have a possible reaction to this combination of drugs. We can check this whole scenario by 
constructing a SPARQL query, and in response, Ole Nordmann can be prevented from taking 
the same combination as he is inheriting the same genes. A possible warning can be generated 
for the practitioner responsible for treating Ole, and he may further order some more clinical 




Figure 4.12 query result for hypothetical DDI 
We used the class InteraksjonIkkeVurdert to classify the potential unknown interaction. It 
should be noted that the scenario presented above may be biological incorrect i.e. the medicines 
involved in the case are only used for the demonstration purpose. Similarly, If we have all the 
medicines in our FEST ontology, we can integrate the patient and his history with those 





 Discussion and Conclusion 
This thesis is in a way continuation of the paper that we have submitted. We developed an 
ontological model of FEST and demonstrated the integration of ontology with different 
concepts for drug interaction reasoning. One of our goals was to demonstrate semantic 
interoperability. HL7 is also complying to the same idea and have started implementing 
ontological representation for FHIR specifications in RDF format. The mapping between FEST 
XML and FEST ontology is mostly one-to-one, and concepts such as attributes, and class 
names were mapped using similar notation in most of the cases. Another goal was to generate 
information about potential drug-drug interactions that are not explicitly declared in FEST 
database. We demonstrated one use case of such a scenario by generating possible drug 
interaction based on family history of the patient. This use case has also been submitted in 
paper. We also presented a possible method to classify drug interactions which are listed in 
FEST, based on different mechanisms such as Pharmacodynamic and Pharmacokinetic 
interactions. 
5.1 Future work 
To illustrate the future work, one of the most interesting aspect is that Norwegian Medicine 
Agency (Statens legemiddelverk), being responsible for FEST, is also working on the similar 
project which is to represent FEST as open and linked data [2]. We had a discussion with 
Aleksander Skøyeneie, advisor at Legemiddelverket, and he briefed that they do not have an 
ontological model of FEST at the moment and have only implemented two catalogues as 
ontology. Furthermore, he stated that they would be interested in having a presentation If we 
are able to develop an ontological model and present a demonstration. We hope that we will be 
able present the thesis work to Legemiddelverket and continue working in this direction as this 
may directly help Norwegian healthcare systems. In addition to this, one of the student who 
also worked on the paper, have shown interest in developing an API based on Java and Jena 
libraries to import and map all the data instances automatically from FEST XML database to 
the FEST ontology that we have developed. 
On the other hand, the ontology that we have developed can be integrated with other ontologies 
such as FHIR ontology and SNOMED CT for semantic interoperability. FHIR specifications, 
developed by HL7, are used to exchange clinical information across different systems. 
Information related to drugs, patient’s history, and family medical history is represented by 
FHIR resources [32]. By integrating FEST ontology with FHIR ontology, we can import 
clinical data from any system utilizing FHIR, and generate implicit data based on user defined 
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rules. The figure below shows the architecture overview of our paper, and the scenario 
described above can clearly fit in this case. 
 
The pharmacological data in the figure above is can be imported from FEST ontology. 
SNOMED CT is a nomenclature used to provide standard vocabulary for clinical terms [11]. 
In the current FEST database, drugs and substances are identified by ATC coding system. We 
can integrate FEST ontology with SNOMED ontology to identify drugs based on two different 
coding systems. We can also combine the pharmacological drug data used in Norway with the 
data from other sources based on SNOMED. In this way we can generate inferred data about 
drug usage in Norwegian systems compared with other systems from the world. The other 
systems will also be able to utilize the pharmacological drug data used in Norway, which will 
mutually help in better and safe medication. This is just an example use case, and once 
integrated, there may be several possibilities. 
A use case that we have presented to classify drug interactions according to different 
mechanisms may also be extended. A more detailed and biologically correct definition of 
interaction mechanisms in the class hierarchy will result in more effective classification of drug 
interactions. 
Certainly, there are some shortcomings or concerns that should be addressed before 
implementing the solution discussed in this thesis in real world. The data instances we have 
used for the demonstration purpose are imported manually from the FEST XML database, and 
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preferably this should have been done automatically. However, in the first phase of the thesis, 
we tried to implement it automatically by using some existing XML to RDF/OWL parsing 
tools  such as JXML2OWL API8 , Ontmalizer9 , and TopBraid composer10, which are. None 
of the tools provided a meaningful or ordered output structure of data. Because one of the point 
of interest was to demonstrate drug interaction inferencing based on family history, and 
working on automatic mapping of whole FEST database would then mean more focus on XML 
parsing techniques rather than drug interactions and their mechanisms. After discussing the 
implementation possibilities with supervisors, we decided to develop the ontology and import 
some of the data manually for the purpose of demonstration. 
Another shortcoming, or we will rather say “limitation”, is the fact some of the resources of 
FEST are not mapped in this thesis. We decided to exclude the mapping of Refusjon, Vilkår, 
and Byttegruppe catalogues. However, a complete system (API, web application etc.) based on 
FEST ontology should also have these catalogues. The reason for the exclusion of these 
catalogues is that they are not much related with the drugs directly. Although these catalogues 
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7.1 APPENDIX A : Glossary 
 
Merkevare     Branded product 
Kodeverk    Kodeverk 
Handelsvarer    Commodities 
Enhet for dosering   Dosage unit 
DoseringsForslag   Dosage suggestion 
GodkjentMaksimaldose  Approved max dosage 
GodkjentNormaldose   Approved Normal dosage 
Interaksjon    Interaction 
KodeVerk    Coding system 
Varsel fra SLV   Notification from Statens Legemiddelverk 
Pakningsstørrelse   Package size 
Paknigstype    Package type 
LegemiddelMerkevare  Branded medicine 
LegemiddelPakning   Medicine Packaging 
LegemiddelVirkestoff  Medicine substance 
LegemiddelForslag   Medicine suggestion 
Pakningsinformasjon   Packaging Infromation 
Referanseelement   Reference Element 
Lenke     Link 
Legemiddeldose   Medicine dosage 
Forskrivning    Prescription 
Preparattype    Product type 
Substans    Substance 
Substansgruppe   Substance groups 
Byttegruppe    Substitution group 
Diagnose    Diagnosis 
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<Prefix name="" IRI="http://www.semanticweb.org/hobbit/ontologies/2017/3/mergedOntology#"/> 
<Prefix name="owl" IRI="http://www.w3.org/2002/07/owl#"/> 
<Prefix name="rdf" IRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#"/> 
<Prefix name="xml" IRI="http://www.w3.org/XML/1998/namespace"/> 
<Prefix name="xsd" IRI="http://www.w3.org/2001/XMLSchema#"/> 
<Prefix name="rdfs" IRI="http://www.w3.org/2000/01/rdf-schema#"/> 














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Hemmet metabolisme av irinotkan til inaktiv metabolitt 





<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Dosetilpasning: Produsenten av itrakonazol og noen 
produsenter av irinotekan kontraindiserer kombinasjonen på grunn av irinotekans smale terapeutiske bredde. På grunn av lang 
halveringstid for itrakonazol kan interaksjonen vedvare i 1-2 uker etter avsluttet behandling med itrakonazol. Hvis midlene likevel må 
kombineres, kan irinotekandosen forsøksvis reduseres til halvparten av vanlig dose. 



















<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Økt konsentrasjon av den aktive irinotekanmetabolitten 




















































<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Polk RE, et al. Pharmacokinetic interaction between 















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































<Literal xml:lang="no" datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Varsel fra SLV har som hensikt å gi 
forskriver, utleverer og bruker viktig informasjon knyttet til legemidler. Varsel fra SLV inneholder informasjon med en gitt 
































<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">A = Aktiv (Active) 




















<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">1 = Interaksjonsstudier (Interaction Studies) 
2 = Kasusrapporter (Case Studies) 
3 = Interaksjonsstudier og kasusrapporter (Interaction and Case studies) 









<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Classification of interactions 
 
1 = Bør unngås (Should be avoided) 
2 = Forholdsregler bør tas (Precaution should be taken) 
3 = Ingen tiltak nødvendig (No action needed) 
 
NOTE: it can also be implemented by using Objects of class Kodeverk 





<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Use following notation: 
A = Reseptgruppe A 
B = Reseptgruppe B 
C = Reseptgruppe C 
CF = Reseptgruppe CF 
F = Reseptgruppe F 
K = Kosttilskudd (Supplements) 
 





<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Forklaring kodeverk: 
1 = Skal ikke søkes: Alle legemidler som er godkjent fra Legemiddelverket eller er NAF-preparat/magistrell fra Apotekforeningen/fremstilt 
på sykehusapotek vil være merket med denne verdien. 
2 = Søknad vurderes av apotek: Brukes for uregistrerte legemidler (Preparattype = Krever godkj. fritak) der apotek må vurdere om det kan 
brukes notifisering eller om søknad må sendes til Legemiddelverket. 





Kodeverk: 7422 Søknadstype 
 
1 = Skal ikke søkes 
2 = Søknad vurderes av apotek 










<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Preservance Temperature 
R = Rom (Room) 15-25 grader 
K = Kaldt (Cold)  2-8 grader 
















<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Was used to specify the time of download. In our case, 













<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">Hvilken type et varsel er av. Varsel fra SLV er 
kategorisert i ulike typer: et eksempel på en type er &quot;sikkerhetsinformasjon&quot;. Et slikt Varsel fra SLV vil inneholde informasjon 
om viktige sikkerhetsoppdateringer og nye alvorlige bivirkninger. Et annet eksempel er &quot;leveringssvikt&quot;. Dette vil inneholde 






<Literal datatypeIRI="http://www.w3.org/1999/02/22-rdf-syntax-ns#PlainLiteral">I = Intervall (interval) 
L = Lik (same) 
M = Mindre enn (lower/less than) 











<!-- Generated by the OWL API (version 4.2.6.20160910-2108) https://github.com/owlcs/owlapi --> 
 
 
 
